We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+9.46%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$11.9B
AUM Growth
+$1.4B
(+13%)
Cap. Flow
+$748M
Cap. Flow
% of AUM
6.3%
Top 10 Holdings %
Top 10 Hldgs %
12.11%
Holding
747
New
202
Increased
220
Reduced
153
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$134M |
| 2 |
STMicroelectronics
STM
|
+$103M |
| 3 |
Meta Platforms (Facebook)
META
|
+$89.9M |
| 4 |
MetLife
MET
|
+$71.9M |
| 5 |
Gilead Sciences
GILD
|
+$70.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$161M |
| 2 |
Eli Lilly
LLY
|
+$153M |
| 3 |
MRSH
Marsh
MRSH
|
+$123M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$91.8M |
| 5 |
Electronic Arts
EA
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.43% |
| 2 | Technology | 17.4% |
| 3 | Industrials | 8.07% |
| 4 | Energy | 6.4% |
| 5 | Financials | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XOMA
451
DELISTED
Xoma
XOMA
| $2.52M | 0.02% |
95,339
+23,128
| +32% | +$626K |
|
452
Playtika
PLTK
$1.25B
| $2.52M | 0.02% |
+318,208
| New | +$2.39M |
|
|
TERN
453
DELISTED
Terns Pharmaceuticals
TERN
| $2.51M | 0.02% |
301,224
-443,820
| -60% | -$3.65M |
|
454
Xylem
XYL
$28.2B
| $2.48M | 0.02% |
+18,357
| New | +$2.46M |
|
455
State Street SPDR S&P 500 ETF Trust
SPY
$818B
| $2.45M | 0.02% |
+4,262
| New | +$2.36M |
|
456
Loar Holdings
LOAR
$6.79B
| $2.44M | 0.02% |
32,779
-16,574
| -34% | -$1.1M |
|
457
Portillo's
PTLO
$317M
| $2.44M | 0.02% |
+180,842
| New | +$2.02M |
|
458
Biomea Fusion
BMEA
$90.4M
| $2.44M | 0.02% |
241,107
+4,688
| +2% | +$30.5K |
|
|
SUM
459
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $2.41M | 0.02% |
+61,844
| New | +$2.38M |
|
460
Fulcrum Therapeutics
FULC
$288M
| $2.39M | 0.02% |
670,807
+169,506
| +34% | +$1.26M |
|
461
Teradyne
TER
$60.2B
| $2.36M | 0.02% |
+17,617
| New | +$2.37M |
|
462
Tarsus Pharmaceuticals
TARS
$2.85B
| $2.35M | 0.02% |
+71,569
| New | +$2.01M |
|
|
SCPH
463
DELISTED
scPharmaceuticals
SCPH
| $2.29M | 0.02% |
+501,608
| New | +$2.43M |
|
|
EWCZ
464
DELISTED
European Wax Center
EWCZ
| $2.27M | 0.02% |
+334,082
| New | +$2.59M |
|
465
Nektar Therapeutics
NKTR
$2.48B
| $2.25M | 0.02% |
115,445
+73,918
| +178% | +$1.41M |
|
466
Owens Corning
OC
$12.1B
| $2.23M | 0.02% |
12,635
-8,812
| -41% | -$1.48M |
|
|
MRNS
467
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $2.23M | 0.02% |
1,264,271
-2,715,334
| -68% | -$3.79M |
|
468
Under Armour
UAA
$2.73B
| $2.19M | 0.02% |
+246,156
| New | +$1.83M |
|
469
Mueller Water Products
MWA
$4.24B
| $2.19M | 0.02% |
100,890
-129,225
| -56% | -$2.6M |
|
470
VanEck Semiconductor ETF
SMH
$71.8B
| $2.18M | 0.02% |
8,888
+1,588
| +22% | +$386K |
|
471
Armstrong World Industries
AWI
$7.78B
| $2.16M | 0.02% |
16,451
+6,378
| +63% | +$789K |
|
472
Zura Bio
ZURA
$542M
| $2.11M | 0.02% |
518,656
+2,757
| +0.5% | +$10.3K |
|
473
Eledon Pharmaceuticals
ELDN
$267M
| $2.1M | 0.02% |
842,892
+167,649
| +25% | +$449K |
|
|
GRVY
474
GRAVITY
GRVY
$425M
| $2.07M | 0.02% |
34,885
-41,930
| -55% | -$2.88M |
|
475
Taysha Gene Therapies
TSHA
$1.82B
| $2.07M | 0.02% |
1,027,494
+1,225
| +0.1% | +$2.69K |
|
Similar funds
TCIIS
UIM
VAI
KK
Woodline Partners's Q3 2024 Portfolio in Review
As of Q3 2024, Woodline Partners held 747 positions worth $11.9B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Woodline Partners deployed $748M of net new capital in Q3 2024, opening 202 new positions and adding to 220 existing holdings. Its largest new stake was ASML: 149,876 shares worth $125M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 42% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Eli Lilly, an estimated $153M trimmed.
- Woodline Partners's largest Q3 2024 buy was ASML: 149,876 shares worth $125M.
- Woodline Partners added most to STMicroelectronics in Q3 2024, an estimated $103M increase.
- Woodline Partners's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $153M.
- Woodline Partners fully exited TE Connectivity in Q3 2024, selling an estimated $161M.
- Woodline Partners's ten largest holdings make up 12% of its $11.9B portfolio in Q3 2024.
- Woodline Partners opened 202 new positions and closed 161 in Q3 2024.
- Woodline Partners's portfolio value rose 13% quarter-over-quarter to $11.9B.
Based on Woodline Partners's 13F filing for Q3 2024, filed 14 Nov 2024.